HCPs are unwanted impurities requiring removal during manufacturing, but new trehalose technology significantly reduces HCPs ...

About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

As therapeutic antibodies evolve, the industry is moving away from a one-size-fits-all chromatography approach. With an increasing share of non-traditional monoclonal antibodies (mAbs)—including ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Antibody therapies are critical in treating various diseases such as cancer and ...

Danaher Corp.’s Cytiva units dropped a lawsuit that alleged JSR Corp.’s Amsphere A3 product infringes three patents for technology used to purify antibodies for medical treatments. Cytiva Bioprocess R ...

Deriving antibodies from plasma involves a multi-step process, from plasma collection to antibody purification and quality control, ensuring the final product is safe and effective for therapeutic, ...

Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma ...

The past decade has brought a rise in the use of disposable products for biopharmaceutical downstream processing, especially in chromatographic purification (1, 2). Applying such materials in ...